精神心理科指南

订阅

MedSci主页 / 所有栏目 / 精神心理科指南

2020 NICE指南：成人复杂精神病的康复治疗（NG.181）

2020-08-19 英国国家卫生与临床优化研究所 NICE官网

精神病

2020年8月，英国国家卫生与临床优化研究所 (NICE)发布了成人复杂精神病的康复治疗指南。指南主要涵盖了成人复杂精神病患者心理健康康复的相关内容，目的是确保患者在需要的时候能够进行康复。

中文标题：

2020 NICE指南：成人复杂精神病的康复治疗（NG.181）

英文标题：

NICE guideline [NG181]:Rehabilitation for adults with complex psychosis

发布机构：

英国国家卫生与临床优化研究所

发布日期：

2020-08-19

简要介绍：

2020年8月，英国国家卫生与临床优化研究所 (NICE)发布了成人复杂精神病的康复治疗指南。指南主要涵盖了成人复杂精神病患者心理健康康复的相关内容，目的是确保患者在需要的时候能够进行康复。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 NICE指南：成人复杂精神病的康复治疗（NG.181.pdf)] GetToolGuiderByIdResponse(projectId=1, id=64bee1c0019619db, title=2020 NICE指南：成人复杂精神病的康复治疗（NG.181）, enTitle=NICE guideline [NG181]:Rehabilitation for adults with complex psychosis, guiderFrom=NICE官网, authorId=0, author=, summary=2020年8月，英国国家卫生与临床优化研究所 (NICE)发布了成人复杂精神病的康复治疗指南。指南主要涵盖了成人复杂精神病患者心理健康康复的相关内容，目的是确保患者在需要的时候能够进行康复。, cover=https://img.medsci.cn/2020831/1598887040523_2020535.jpg, journalId=0, articlesId=null, associationId=85, associationName=英国国家卫生与临床优化研究所, associationIntro=英国国家卫生与临床优化研究所（NICE，National Institute for Health and Clinical Excellence）是NHS的组织，设在伦敦和曼彻斯特。NICE成立于1999年4月1日，目标是确保每个英格兰和威尔士人平等享有NHS医疗的机会。NICE制定指南，设定质量标准，管理国家数据库，为NHS、当地权威部门和其他组织提供指南。, copyright=0, guiderPublishedTime=Wed Aug 19 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年8月，英国国家卫生与临床优化研究所 (NICE)发布了成人复杂精神病的康复治疗指南。指南主要涵盖了成人复杂精神病患者心理健康康复的相关内容，目的是确保患者在需要的时候能够进行康复。</p> </div> </div> </div>, tagList=[TagDto(tagId=624, tagName=精神病)], categoryList=[CategoryDto(categoryId=13, categoryName=精神心理科, tenant=100), CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=624, guiderKeyword=精神病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5023, appHits=121, showAppHits=0, pcHits=820, showPcHits=4902, likes=0, shares=4, comments=6, approvalStatus=1, publishedTime=Mon Aug 31 23:21:54 CST 2020, publishedTimeString=2020-08-19, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Mon Aug 31 23:17:27 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 12:27:09 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 NICE指南：成人复杂精神病的康复治疗（NG.181.pdf)])
2020 NICE指南：成人复杂精神病的康复治疗（NG.181.pdf
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=951737, encodeId=ec32951e37db, content=😎😎, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=459d5467529, createdName=ms1000000580800231, createdTime=Sun Mar 28 07:43:34 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951240, encodeId=ce599512405b, content=很好的内容, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=459d5467529, createdName=ms1000000580800231, createdTime=Thu Mar 25 18:11:43 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948637, encodeId=86cf94863e11, content=0, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2c25469619, createdName=读一读, createdTime=Tue Mar 16 12:08:08 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892024, encodeId=9f7c89202464, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201014/5427f3ebf4bf43ac895d9d4cb45bc23d/c3ab4e26698042c8ad329970f658d624.jpg, createdBy=67085183037, createdName=146fea89m53(暂无昵称), createdTime=Wed Oct 14 14:49:25 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887352, encodeId=a79088e3520a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Tue Sep 22 14:18:19 CST 2020, time=2020-09-22, status=1, ipAttribution=)]
    2021-03-28 ms1000000580800231

    😎😎

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=951737, encodeId=ec32951e37db, content=😎😎, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=459d5467529, createdName=ms1000000580800231, createdTime=Sun Mar 28 07:43:34 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951240, encodeId=ce599512405b, content=很好的内容, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=459d5467529, createdName=ms1000000580800231, createdTime=Thu Mar 25 18:11:43 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948637, encodeId=86cf94863e11, content=0, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2c25469619, createdName=读一读, createdTime=Tue Mar 16 12:08:08 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892024, encodeId=9f7c89202464, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201014/5427f3ebf4bf43ac895d9d4cb45bc23d/c3ab4e26698042c8ad329970f658d624.jpg, createdBy=67085183037, createdName=146fea89m53(暂无昵称), createdTime=Wed Oct 14 14:49:25 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887352, encodeId=a79088e3520a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Tue Sep 22 14:18:19 CST 2020, time=2020-09-22, status=1, ipAttribution=)]
    2021-03-25 ms1000000580800231

    很好的内容

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=951737, encodeId=ec32951e37db, content=😎😎, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=459d5467529, createdName=ms1000000580800231, createdTime=Sun Mar 28 07:43:34 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951240, encodeId=ce599512405b, content=很好的内容, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=459d5467529, createdName=ms1000000580800231, createdTime=Thu Mar 25 18:11:43 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948637, encodeId=86cf94863e11, content=0, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2c25469619, createdName=读一读, createdTime=Tue Mar 16 12:08:08 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892024, encodeId=9f7c89202464, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201014/5427f3ebf4bf43ac895d9d4cb45bc23d/c3ab4e26698042c8ad329970f658d624.jpg, createdBy=67085183037, createdName=146fea89m53(暂无昵称), createdTime=Wed Oct 14 14:49:25 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887352, encodeId=a79088e3520a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Tue Sep 22 14:18:19 CST 2020, time=2020-09-22, status=1, ipAttribution=)]
    2021-03-16 读一读

    0

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=951737, encodeId=ec32951e37db, content=😎😎, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=459d5467529, createdName=ms1000000580800231, createdTime=Sun Mar 28 07:43:34 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951240, encodeId=ce599512405b, content=很好的内容, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=459d5467529, createdName=ms1000000580800231, createdTime=Thu Mar 25 18:11:43 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948637, encodeId=86cf94863e11, content=0, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2c25469619, createdName=读一读, createdTime=Tue Mar 16 12:08:08 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892024, encodeId=9f7c89202464, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201014/5427f3ebf4bf43ac895d9d4cb45bc23d/c3ab4e26698042c8ad329970f658d624.jpg, createdBy=67085183037, createdName=146fea89m53(暂无昵称), createdTime=Wed Oct 14 14:49:25 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887352, encodeId=a79088e3520a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Tue Sep 22 14:18:19 CST 2020, time=2020-09-22, status=1, ipAttribution=)]
    2020-10-14 146fea89m53(暂无昵称)

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=951737, encodeId=ec32951e37db, content=😎😎, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=459d5467529, createdName=ms1000000580800231, createdTime=Sun Mar 28 07:43:34 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951240, encodeId=ce599512405b, content=很好的内容, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=459d5467529, createdName=ms1000000580800231, createdTime=Thu Mar 25 18:11:43 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948637, encodeId=86cf94863e11, content=0, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2c25469619, createdName=读一读, createdTime=Tue Mar 16 12:08:08 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892024, encodeId=9f7c89202464, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201014/5427f3ebf4bf43ac895d9d4cb45bc23d/c3ab4e26698042c8ad329970f658d624.jpg, createdBy=67085183037, createdName=146fea89m53(暂无昵称), createdTime=Wed Oct 14 14:49:25 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887352, encodeId=a79088e3520a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Tue Sep 22 14:18:19 CST 2020, time=2020-09-22, status=1, ipAttribution=)]
    2020-09-22 飞翔的乌龟

    学习了

    0

相关指南

抗精神病药物的临床试验技术指导原则

国家药品监督管理局药品审评中心（CDE） · 2019-10-31

2017 ACEP临床决策：成年精神病患者急诊室诊断和管理要点

美国急诊医师学会(ACEP,American College of Emergency Physicians) · 2017-04-01

2016 亚太地区近期发作的精神病患者的最佳照护建议

国外精神科相关专家小组（统称） · 2016-04-11

2016 BAP指南：精神病和抗精神病药物治疗相关性体重增加，代谢紊乱和心血管风险的管理

英国精神药理协会(BAP,British Association for Psychopharmacology) · 2016-05-04

拓展阅读

2016 BAP指南：精神病和抗精神病药物治疗相关性体重增加，代谢紊乱和心血管风险的管理

英国精神药理协会(BAP,British Association for Psychopharmacology) · 2016-05-04

2016 亚太地区近期发作的精神病患者的最佳照护建议

国外精神科相关专家小组（统称） · 2016-04-11

2017 ACEP临床决策：成年精神病患者急诊室诊断和管理要点

美国急诊医师学会(ACEP,American College of Emergency Physicians) · 2017-04-01

抗精神病药物的临床试验技术指导原则

国家药品监督管理局药品审评中心（CDE） · 2019-10-31

NICE指南：患有复杂精神病的成年人的康复 2020

国家卫生和护理研究所（NICE） · 2020-11-06